News

Class Action Filed for MGP Ingredients, Inc. (NASDAQ: MGPI) Investors

Class Action Filed for MGP Ingredients, Inc. (NASDAQ: MGPI) Investors

Overview of the Class Action Against MGP Ingredients

MGP Ingredients, Inc. (NASDAQ: MGPI), a prominent player in the food and beverage sector, is currently facing a class action lawsuit filed by Glancy Prongay & Murray LLP. This announcement highlights significant developments for the investors who purchased MGPI common stock during the specified Class Period. It serves as a critical reminder of the potential risks that investors face in the market.

Details of the Class Action Lawsuit

The lawsuit pertains to investors who acquired common stock in MGPI from May 4, 2023, through October 30, 2024. The firm emphasizes the importance of filing a lead plaintiff motion by February 14, 2025, for those affected. This provides affected investors a chance to advocate for their rights and seek justice regarding their investments.

Investors suffering losses due to potential misleading statements made by the company can take proactive steps to recover their investments. Glancy Prongay & Murray LLP urges all members of the class to submit their contact information to discuss their options and rights in light of this lawsuit.

Financial Disclosures Impacting Stock Value

On October 17, 2024, MGP Ingredients reported an expected 24% drop in sales for the third quarter of 2024 compared to the same quarter in the previous year. The company cited softening demand and excess inventories as primary factors for their cautious outlook.

This news led to a notable decline in MGPI's stock price by $19.71, a drop of 24.2%, closing at $61.86 per share the following day. Such fluctuations significantly affect investor confidence and emphasize the relevance of the ongoing legal proceedings.

Subsequent Impacts on Operations and Stock

Further developments on October 31, 2024, revealed that excess inventories would affect sales even more in 2025 than previously anticipated. This prompted the firm to make operational adjustments aimed at cost-saving measures.

As a reaction to this news, MGPI's stock fell further by $8.27, or 14.7%, closing at $48.04 per share, causing further concern among investors regarding the company's future performance.

Allegations Stated in the Complaint

The complaint filed by Glancy Prongay & Murray LLP outlines the allegations that MGPI and its executives made materially false and misleading statements during the Class Period. The firm claims that important facts regarding the company’s business operations and projections were deliberately concealed from investors.

Specifically, the lawsuit points out that the company experienced a slowdown in product consumption and an oversupply condition, which were not disclosed to the public. Such omissions have left investors in the dark regarding MGP Ingredients' realistic financial conditions.

Investor Rights and Recommendations

For investors who acquired MGPI shares during the defined period, there is a path forward. Investors may have the option to become a lead plaintiff and seek restitution for their losses by the stipulated date. This demonstrates the necessity for investors to stay informed and proactive about their investments.

Conclusion

This situation sheds light on the complexities of investing and the importance of staying informed. The actions of MGP Ingredients, Inc. have led to substantial legal challenges that could impact its investor base significantly. It serves as a crucial lesson regarding market fluctuations and corporate responsibility.

Frequently Asked Questions

What is the class action lawsuit about?

The lawsuit is a legal action filed on behalf of investors who purchased shares of MGPI and alleges that the company made misleading statements about its business performance.

Who can participate in the class action?

Any investor who bought MGPI common stock between May 4, 2023, and October 30, 2024, can participate and potentially recover losses.

What are the deadlines regarding this lawsuit?

Investors must file a lead plaintiff motion by February 14, 2025, to be actively involved in the proceedings.

How can I learn more about my rights as a shareholder?

Interested investors should contact Glancy Prongay & Murray LLP or consult a legal expert to understand their rights and the options available to them.

What happened to MGPI's stock price recently?

MGPI saw its stock price fall significantly due to disappointing financial disclosures, with declines noted on October 18, 2024, and October 31, 2024.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

OneAscent Welcomes Monica Stoudemire as New CCO

Updated Category News Views 5

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 6

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 3

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 2

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 8

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in Dell Technologies: A Remarkable Growth Story

Updated Category News Views 266

Investing in Dell Technologies: A Remarkable Growth Story Dell Technologies (NYSE: DELL) has shown impressive performance over the past five years, significantly surpassing market averages. With an annualized growth rate of 16.74%, investors have reaped substantial rewards from the company’s strong strategy and execution, resulting in an average annual return of 29.36%....

Continue Reading
SoundExchange Highlights 2025's Musical Achievements and Trends

Updated Category News Views 109

Looking Back at 2025: Top Tracks and Emerging Talents As the year comes to a close, SoundExchange has unveiled its annual compilation of the Top Tracks and Breakout Creators for 2025. The selection showcases an exciting array of artists, highlighting the most streamed songs and rapidly rising musicians over the past year, fueled by a remarkable digital music landscape....

Continue Reading
ClimateTech Connect: Pioneering a Green Future in Washington

Updated Category News Views 324

ClimateTech Connect Conference Overview ClimateTech Connect is set to revolutionize the discourse around climate resilience and innovation with its upcoming global conference in Washington, DC. This unique event, scheduled for April 15-16, 2025, is designed to unite thought leaders, innovators, policymakers, and industry experts. The aim is to delve into the fusion of...

Continue Reading
Laminar Pharma Shows Promising Results for LAM561 in Glioblastoma

Updated Category News Views 186

Laminar Pharma's Positive Clinical Trial Results Laminar Pharma has recently disclosed encouraging updates regarding its clinical trial evaluating LAM561, an innovative cancer treatment for newly diagnosed glioblastoma patients. This clinical trial is focused particularly on those with MGMT-methylated tumors, a common prognostic factor in this aggressive form of brain...

Continue Reading
FTC Solar Set to Reveal Q4 and Yearly Financial Results Soon

Updated Category News Views 153

FTC Solar to Report Financial Results FTC Solar, Inc. (Nasdaq: FTCI), renowned as a top-tier provider of solar tracker systems and engineering services, has shared plans to announce its financial outcomes for the fourth quarter and the entire year of 2024. This important announcement will occur prior to market opening on a Monday. Details of the Announcement On the day of...

Continue Reading